A Comparative, Retrospective Chart Review of Intended Dwell Time of a PICC Line
1 other identifier
observational
121
1 country
1
Brief Summary
This is a retrospective, matched pair comparative post market review of 4Fr Single Lumen PICC lines. The subjects will be matched by the timeframe of when the HydroPICCs were inserted.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 13, 2020
CompletedFirst Submitted
Initial submission to the registry
December 1, 2020
CompletedFirst Posted
Study publicly available on registry
December 7, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 23, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 23, 2021
CompletedMay 26, 2021
May 1, 2021
5 months
December 1, 2020
May 25, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Intended dwell time based on a comparison of the actual dwell time to the intended time
Comparison of actual vs intended dwell times of each arm
August 2020 through October 2020
Secondary Outcomes (1)
Comparison of failure rates
August 2020 through October 2020
Study Arms (2)
HydroPICC
Cohort who received the HydroPICC
Standard of Care
Cohort who received something different than HydroPICC
Interventions
Eligibility Criteria
Any patients at the study site that received a 4 Fr single lumen PICC line from Aug 2020 through Oct 2020.
You may qualify if:
- Subjects who have been inserted with the HydroPICC during a specific time range.
- During the same time period, any competitor 4 Fr single lumen placed.
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Joseph Bunch
Romeoville, Illinois, 60446, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Joseph Bunch
ProVasc
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 1, 2020
First Posted
December 7, 2020
Study Start
November 13, 2020
Primary Completion
April 23, 2021
Study Completion
April 23, 2021
Last Updated
May 26, 2021
Record last verified: 2021-05
Data Sharing
- IPD Sharing
- Will not share